Home
Live Updates
Apellis Pharmaceuticals Announces FDA Approval Of EMPAVELI Injector : comparemela.com
Apellis Pharmaceuticals Announces FDA Approval Of EMPAVELI Injector
Apellis Pharmaceuticals, Inc. (APLS) announced the FDA has approved the EMPAVELI Injector. It is a single-use, on-body device designed to enhance self-administration of EMPAVELI, which is approved for adults with paroxysmal nocturnal hemoglobinuria.
Related Keywords
,
Bloomberg ,
Invitae Common Hereditary Cancers Panel ,
Apple Inc ,
Motion Inc ,
Google ,
Microsoft Corp ,
Us Consumer Product Safety Commission ,
Microsoft ,
Drug Administration ,
Common Hereditary Cancers Panel ,
California Based Future Motion ,
Self Balancing Electric Skateboards ,
Product Safety Commission ,
Fda ,
Apellis Pharmaceuticals ,
Empaveli ,
comparemela.com © 2020. All Rights Reserved.